For research use only. Not for therapeutic Use.
Fenofibrate（Cat No.:A001029）is a lipid-regulating medication primarily used to treat hyperlipidemia, particularly elevated triglyceride levels and low HDL cholesterol. It belongs to the fibrate class of drugs and works by activating peroxisome proliferator-activated receptor alpha (PPARα), which enhances the breakdown of fatty acids and promotes the metabolism of lipoproteins in the liver. This action leads to a reduction in triglyceride levels and an increase in HDL cholesterol. Fenofibrate is often prescribed alongside lifestyle changes and other lipid-lowering agents to reduce the risk of cardiovascular diseases and improve overall lipid profiles.
| Catalog Number | A001029 |
| CAS Number | 49562-28-9 |
| Synonyms | 49562-28-9; Procetofen; Lipanthyl; Lipantil; Antara |
| Molecular Formula | C20H21ClO4 |
| Purity | ≥95% |
| Target | Cell Cycle/DNA Damage |
| Solubility | >12.8mg/mL in DMSO |
| Storage | -20°C |
| IUPAC Name | propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate |
| InChI | InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3 |
| InChIKey | YMTINGFKWWXKFG-UHFFFAOYSA-N |
| SMILES | CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl |
